Amy L. Ronneberg's most recent trade in Actuate Therapeutics Inc. was a trade of 15,000 Stock Options done . Disclosure was reported to the exchange on May 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Actuate Therapeutics Inc | Amy L. Ronneberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 15,000 | 15,000 | - | - | Stock Options | |
| Actuate Therapeutics Inc | Amy L. Ronneberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 30,000 | 30,000 | - | - | Non-Qualified Stock Options |